Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxapram for Apnea of Prematurity in Preterm Infants
NCT04430790Phase 3Recruiting
- Sponsor
- Erasmus MC
- Start
- Jun 2020
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of doxapram in apnea of prematurity (AOP), Respiratory Insufficiency (RI), sponsored by Erasmus MC. Started Jun 2020; status: recruiting.
02
Drugs
doxapram
03
Conditions
apnea of prematurity (AOP)Respiratory Insufficiency (RI)
Beyond the preview
Go deeper on NCT04430790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04430790.